FEB 01, 2019 08:42 PM PST

Statin Therapy Reduces Risk of Cardiovascular Complications Regardless of Age

WRITTEN BY: Nouran Amin

A meta-analysis study, from randomized clinical trials, found that regardless of age, statin therapy is effective in decreasing the risk of developing vascular complications. The study also found no-adverse effects on non-vascular mortality or cancer.

"Statins are a useful and affordable drug that reduce heart attacks and strokes in older patients. Until now there has been an evidence gap and we wanted to look at their efficacy and safety in older people. Our analysis indicates that major cardiovascular events were reduced by about a fifth, per mmol/L lower LDL cholesterol, by statin therapy across all age groups. Despite previous concerns we found no adverse effect on cancer or non-vascular mortality in any age group,” says, Dr. Jordan Fulcher of the Cholesterol Treatment Trialists' (CTT) Collaboration based at the University of Sydney NHMRC Clinical Trials Centre, Australia.

Statins are drugs that work to lower cholesterol levels. They are widely prescribed for patients at risk of heart attacks or strokes.

Learn more about how statins work:

The clinical trials placed participants into six age groups to investigate intensive vs standard therapy while studying the effects of major vascular events including coronary events, strokes and coronary revascularizations. They also examined cancer incidence and cause specific mortality. Results of the study were published in The Lancet.

"Even if risk reduction in people older than 75 years is less than expected, statin therapy may still be justified by a high baseline cardiovascular risk, which is usually present in older people. The present meta-analysis makes a case to reduce LDL cholesterol in people at risk of cardiovascular events regardless of age, provided that the benefits outweigh the risks and the patient accepts long term treatment,” says, Bernard M Y Cheung of the Queen Mary Hospital at the University of Hong Kong.

Source: Science Daily

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 13, 2019
Health & Medicine
OCT 13, 2019
High Risk: Seizures and Coma Linked to Use of Synthetic Cannabinoids in Adolescents
A recent study by the American Academy of Pediatrics states that exposure to acute synthetic cannabinoid toxicity is far more dangerous to the adolesc...
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Novel Drug Target for Dilating Microvessels
Medical scientists at Augusta University have discovered a natural occurring chemical that dilates blood vessels dilate as well as signaling larger blood v...
OCT 13, 2019
Genetics & Genomics
OCT 13, 2019
New Gene Editing Technology to Combat Hereditary Diseases
Until recently, many types of gene-editing methods were unable to target critical parts of DNA. Now however, researchers at the Salk Institute have develop...
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
The Three Drugs that Reverse Biological Aging
In the last 100 years, life expectancy in the US has risen from 55 years until 79 (Roser: 2019). And with the continuous development of medicine and scie...
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Adderall is Almost Identical to Crystal Meth
Adderall has a reputation for giving people a feeling of euphoria, increasing energy levels and enhancing abilities to focus and concentrate. And coinciden...
OCT 13, 2019
Genetics & Genomics
OCT 13, 2019
Non-Invasive Gene Therapy Holds Promise for Treating Blindness
Researchers at John Hopkins Medicine have found a way to deliver sight-saving gene therapy to the retina. Having already shown success in treating rates, p...
Loading Comments...